ARTIFICIAL INTELLIGENCE IN DERMATOLOGICAL IMAGE CLASSIFICATION: DIAGNOSTIC ACCURACY, SKIN TONE DISPARITIES, AND CLINICAL GOVERNANCE
DOI:
https://doi.org/10.31435/ijitss.4(52).2026.6380Keywords:
Artificial Intelligence, Dermatology, Skin Cancer, Skin-Lesion Classification, Algorithmic Bias, Clinical GovernanceAbstract
Background: Artificial intelligence (AI) is increasingly used to classify skin lesions from dermoscopic and clinical images, yet high performance in curated datasets may not translate into safe or equitable clinical use.
Objective: This structured narrative review evaluates diagnostic accuracy, skin-tone-related performance disparities, dataset representation, and governance requirements for AI-based skin-lesion classification.
Methods: PubMed/MEDLINE was used as the primary database, supplemented by PubMed Central, Google Scholar, Semantic Scholar, journal websites, and reference-list screening. English-language, peer-reviewed literature published mainly between 2021 and 2026 was synthesised thematically across diagnostic performance, external validity, skin-tone representation, clinical implementation, and governance.
Results: Meta-analytic evidence indicates high sensitivity for AI-based skin-lesion classification, including pooled sensitivity of 0.91 and an HSROC-AUC of 0.88, but lower specificity and substantial heterogeneity limit direct clinical translation. Performance declined in darker skin-tone groups in several external evaluations; in selected models, sensitivity fell between Fitzpatrick types I–II and V–VI. Limited reporting of skin tone, reliance on internally tested or curated datasets, and sparse prospective evidence further constrain generalisability.
Conclusion: AI should be implemented as clinician-supervised decision support rather than as an autonomous diagnostic system. Equitable deployment requires representative datasets, external and subgroup-stratified validation, transparent reporting, defined clinical accountability, regulatory oversight, and continuous post-deployment monitoring.
References
Ang, X. L., & Oh, C. C. (2025). The use of artificial intelligence for skin cancer detection in Asia: A systematic review. Diagnostics, 15(7), 939. https://doi.org/10.3390/diagnostics15070939
Cirone, K., Akrout, M., Abid, L., & Oakley, A. (2024). Assessing the utility of multimodal large language models (GPT-4 Vision and Large Language and Vision Assistant) in identifying melanoma across different skin tones. JMIR Dermatology, 7, e55508. https://doi.org/10.2196/55508
Daneshjou, R., Vodrahalli, K., Novoa, R. A., Jenkins, M., Liang, W., Rotemberg, V., Ko, J., Swetter, S. M., Bailey, E. E., Gevaert, O., Mukherjee, P., Phung, M., Yekrang, K., Fong, B., Sahasrabudhe, R., Allerup, J. A. C., Okata-Karigane, U., Zou, J., & Chiou, A. S. (2022). Disparities in dermatology AI performance on a diverse, curated clinical image set. Science Advances, 8(32), eabq6147. https://doi.org/10.1126/sciadv.abq6147
Escalé-Besa, A., Yélamos, O., Vidal-Alaball, J., Fuster-Casanovas, A., Miró Catalina, Q., Börve, A., Ander-Egg Aguilar, R., Fustà-Novell, X., Cubiró, X., Esquius Rafat, M., López-Sanchez, C., & Marin-Gomez, F. X. (2023). Exploring the potential of artificial intelligence in improving skin lesion diagnosis in primary care. Scientific Reports, 13(1), 4293. https://doi.org/10.1038/s41598-023-31340-1
Heldreth, C. M., Monk, E. P., Clark, A. T., Schumann, C., Eyee, X., & Ricco, S. (2024). Which skin tone measures are the most inclusive? An investigation of skin tone measures for artificial intelligence. ACM Journal on Responsible Computing, 1(1), Article 7, 1–21. https://doi.org/10.1145/3632120
Howard, J. J., Sirotin, Y. B., Tipton, J. L., & Vemury, A. R. (2021). Reliability and validity of image-based and self-reported skin phenotype metrics. IEEE Transactions on Biometrics, Behavior, and Identity Science, 3(4), 550–560. https://doi.org/10.1109/TBIOM.2021.3123550
Li, Z., Koban, K. C., Schenck, T. L., Giunta, R. E., Li, Q., & Sun, Y. (2022). Artificial intelligence in dermatology image analysis: Current developments and future trends. Journal of Clinical Medicine, 11(22), 6826. https://doi.org/10.3390/jcm11226826
Liopyris, K., Gregoriou, S., Dias, J., & Stratigos, A. J. (2022). Artificial intelligence in dermatology: Challenges and perspectives. Dermatology and Therapy, 12(12), 2637–2651. https://doi.org/10.1007/s13555-022-00833-8
Liu, Y., Primiero, C. A., Kulkarni, V., Soyer, H. P., & Betz-Stablein, B. (2023). Artificial intelligence for the classification of pigmented skin lesions in populations with skin of color: A systematic review. Dermatology, 239(4), 499–513. https://doi.org/10.1159/000530225
Marsden, H., Morgan, C., Austin, S., DeGiovanni, C., Venzi, M., Kemos, P., Greenhalgh, J., Mullarkey, D., & Palamaras, I. (2023). Effectiveness of an image analyzing AI-based digital health technology to identify non-melanoma skin cancer and other skin lesions: Results of the DERM-003 study. Frontiers in Medicine, 10, 1288521. https://doi.org/10.3389/fmed.2023.1288521
Medical Device Coordination Group, & Artificial Intelligence Board. (2025). FAQ on interplay between the Medical Devices Regulation (MDR) & In vitro Diagnostic Medical Devices Regulation (IVDR) and the Artificial Intelligence Act (AIA) (MDCG 2025-6/AIB 2025-1). European Commission. https://health.ec.europa.eu/document/download/b78a17d7-e3cd-4943-851d-e02a2f22bbb4_en
Medicines and Healthcare products Regulatory Agency. (2023, June 14). Software and AI as a Medical Device Change Programme roadmap. GOV.UK. https://www.gov.uk/government/publications/software-and-ai-as-a-medical-device-change-programme/software-and-ai-as-a-medical-device-change-programme-roadmap
Patel Housley, P., Samia, A. M., & Motaparthi, K. (2025). Performance evaluation of ChatGPT-4o in dermatological diagnoses across Fitzpatrick skin types. Cureus, 17(7), e87368. https://doi.org/10.7759/cureus.87368
Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence and amending Regulations (EC) No. 300/2008, (EU) No. 167/2013, (EU) No. 168/2013, (EU) 2018/858, (EU) 2018/1139, and (EU) 2019/2144 and Directives 2014/90/EU, (EU) 2016/797, and (EU) 2020/1828 (Artificial Intelligence Act), Official Journal of the European Union, L, 2024/1689 (2024). https://eur-lex.europa.eu/eli/reg/2024/1689/oj
Rezk, E., Eltorki, M., & El-Dakhakhni, W. (2022). Improving skin color diversity in cancer detection: Deep learning approach. JMIR Dermatology, 5(3), e39143. https://doi.org/10.2196/39143
Salinas, M. P., Sepúlveda, J., Hidalgo, L., Peirano, D., Morel, M., Uribe, P., Rotemberg, V., Briones, J., Mery, D., & Navarrete-Dechent, C. (2024). A systematic review and meta-analysis of artificial intelligence versus clinicians for skin cancer diagnosis. npj Digital Medicine, 7(1), 125. https://doi.org/10.1038/s41746-024-01103-x
Sanchez, K., Kamal, K., Manjaly, P., Ly, S., & Mostaghimi, A. (2023). Clinical application of artificial intelligence for non-melanoma skin cancer. Current Treatment Options in Oncology, 24(4), 373–379. https://doi.org/10.1007/s11864-023-01065-4
Sangers, T. E., Wakkee, M., Moolenburgh, F. J., Nijsten, T., & Lugtenberg, M. (2023). Towards successful implementation of artificial intelligence in skin cancer care: A qualitative study exploring the views of dermatologists and general practitioners. Archives of Dermatological Research, 315(5), 1187–1195. https://doi.org/10.1007/s00403-022-02492-3
Schumann, C., Olanubi, G. O., Wright, A., Monk, E., Jr., Heldreth, C., & Ricco, S. (2023). Consensus and subjectivity of skin tone annotation for ML fairness. Advances in Neural Information Processing Systems, 36, 30319–30348. https://proceedings.neurips.cc/paper_files/paper/2023/hash/60d25b3210c92f5ba2002a8e1f1adf1c-Abstract-Datasets_and_Benchmarks.html
Smak Gregoor, A. M., Sangers, T. E., Bakker, L. J., Hollestein, L., Uyl-de Groot, C. A., Nijsten, T., & Wakkee, M. (2023). An artificial intelligence based app for skin cancer detection evaluated in a population based setting. npj Digital Medicine, 6(1), 90. https://doi.org/10.1038/s41746-023-00831-w
Thomas, L., Hyde, C., Mullarkey, D., Greenhalgh, J., Kalsi, D., & Ko, J. (2023). Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance. Frontiers in Medicine, 10, 1264846. https://doi.org/10.3389/fmed.2023.1264846
Tjiu, J.-W., & Lu, C.-F. (2025). Equity and generalizability of artificial intelligence for skin-lesion diagnosis using clinical, dermoscopic, and smartphone images: A systematic review and meta-analysis. Medicina, 61(12), 2186. https://doi.org/10.3390/medicina61122186
Tschandl, P., Akay, B. N., Rosendahl, C., Rotemberg, V., Todorovska, V., Weber, J., Wolber, A. K., Müller, C., Kurtansky, N., Halpern, A., Weninger, W., & Kittler, H. (2026). MILK10k: A hierarchical multimodal imaging-learning toolkit for diagnosing pigmented and nonpigmented skin cancer and its simulators. Journal of Investigative Dermatology, 146(2), 357–364.e7. https://doi.org/10.1016/j.jid.2025.06.1594
Walker, B. N., Blalock, T. W., Leibowitz, R., Oron, Y., Dascalu, D., David, E. O., & Dascalu, A. (2025). Skin cancer detection in diverse skin tones by machine learning combining audio and visual convolutional neural networks. Oncology, 103(5), 413–420. https://doi.org/10.1159/000541573
Weir, V. R., Dempsey, K., Gichoya, J. W., Rotemberg, V., & Wong, A.-K. I. (2024). A survey of skin tone assessment in prospective research. npj Digital Medicine, 7(1), 191. https://doi.org/10.1038/s41746-024-01176-8
World Health Organization. (2021). Ethics and governance of artificial intelligence for health: WHO guidance. https://www.who.int/publications/i/item/9789240029200
World Health Organization. (2023). Regulatory considerations on artificial intelligence for health. https://www.who.int/publications/i/item/9789240078871
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Faustyna Magdalena Kołodziej, Mateusz Lis, Zuzanna Julia Komin, Maryan Liasota, Eliza Zofia Kabat, Michalina Justyna Kozłowska, Krzysztof Konopka, Maciej Kamil Majchrzak, Jakub Juskowiak, Alicja Kwiatkowska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
